Kimia Bioscien.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE285U01025
NSEID:
BSEID: 530313

INR

29.00

-0.55 (-1.86%)

BSENSE

Dec 05

BSE+NSE Vol: 1.09 k

{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.00",
    "chg": -0.55,
    "chgp": "-1.86%",
    "dir": -1,
    "prev_price": "29.55",
    "mcapval": "142.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE285U01025",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.09 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kimia Bioscien. Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-bioscien-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3748063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscien_mojoScore_3748063.png",
        "date": "2025-12-05 10:11:01",
        "description": "Kimia Bioscien., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges in its operational and market performance."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs2609-amidst-continued-downtrend-3741786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3741786.png",
        "date": "2025-12-02 12:42:30",
        "description": "Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs272-amidst-continued-downtrend-3738368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3738368.png",
        "date": "2025-12-01 11:12:33",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs272-amidst-continued-downtrend-3738369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3738369.png",
        "date": "2025-12-01 11:12:33",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs284-3735819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_priceRelatedfactors_3735819.png",
        "date": "2025-11-28 15:07:24",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Why is Kimia Bioscien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kimia-bioscien-fallingrising-3721872",
        "imagepath": "",
        "date": "2025-11-22 00:31:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Stock Performance Against Benchmarks</strong></p>\n<p>Kimia Biosciences has underperformed markedly compared to the broader market indices over multiple time horizons. Over the past week, the stock declined by 7.59%, while the Sensex gained 0.79%. This negative trend extends over longer periods, with the stock falling 8.83% in the last month and a steep 30.59% over the past year, contrasting sharply with the Sensex’s 10.47% gain during the same period. Even over three and five years, the stock has lagged significantly, registering losses of 19.88% and 26.81% respectively, while the Sensex surged by 39.39% and 94.23%. These figures underscore persistent underperformance and investor caution surrounding the company.</p>\n<p><strong>Intraday Volatility and Trading Patterns</strong></p>\n<p>On 21-N..."
      },
      {
        "title": "Kimia Biosciences Q2 FY26: Margin Compression Overshadows Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/kimia-biosciences-q2-fy26-margin-compression-overshadows-revenue-growth-3718748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_quaterlyResult_3718748.png",
        "date": "2025-11-18 16:37:16",
        "description": "Kimia Biosciences Ltd., a Gurgaon-based pharmaceutical company specialising in bulk drug manufacturing, reported net profit of ₹1.02 crores for Q2 FY26, marking a sequential increase of 70.00% from ₹0.60 crores in Q1 FY26. However, year-on-year comparison reveals a concerning decline of 36.65% from ₹1.61 crores in Q2 FY25. The company's stock, trading at ₹34.00 with a modest market capitalisation of ₹159 crores, has struggled significantly, declining 27.66% over the past year whilst the broader Sensex gained 9.48%."
      },
      {
        "title": "Kimia Biosciences Financial Trend Shifts to Flat Amid Mixed Quarterly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-q3-2025-financial-trend-shifts-to-flat-amid-margin-pressures-3712223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_fintrenddot_3712223.png",
        "date": "2025-11-18 16:00:29",
        "description": "Kimia Biosciences, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable adjustment in its financial trend parameter, moving from a negative to a flat evaluation in the quarter ending September 2025. This shift reflects a stabilisation in key financial metrics despite ongoing challenges in profitability and margin performance."
      },
      {
        "title": "Is Kimia Bioscien. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kimia-bioscien-overvalued-or-undervalued-3709667",
        "imagepath": "",
        "date": "2025-11-18 08:18:31",
        "description": "As of 17 November 2025, the valuation grade for Kimia Bioscien. has moved from fair to attractive, indicating a positive shift in its market perception. The company is currently considered undervalued, especially when compared to its peers in the pharmaceuticals and biotechnology sector. Key ratios include a PE Ratio of 19.11, an EV to EBITDA of 10.35, and an impressive ROE of 82.13%. \n\nIn comparison to its peers, Kimia Bioscien. stands out with a significantly lower PEG Ratio of 0.11, while Sun Pharma. is deemed expensive with a PE Ratio of 36.69 and an EV to EBITDA of 24.22. Other peers like Divi's Lab and Torrent Pharma are also classified as very expensive, with PE Ratios of 69.78 and 59.48, respectively. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -27.62% compared to the Sensex's 8.72%, the valuation metrics suggest that Kimia Bioscien. presents a compellin..."
      }
    ],
    "total": 172,
    "sid": "263659",
    "stock_news_url": "https://www.marketsmojo.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "02-Dec-2025",
      "details": "Outcome of Board meeting under Regulation 30 of SEBI(Listing Obligations and disclosures Requirements) regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Proposed Appointment Of Secretarial Auditor In Casual Vacancy Due To Non-Availability Of Previously Appointed Secretarial Auditor.",
      "datetime": "28-Nov-2025",
      "details": "Intimation regarding proposed appointment of secretarial auditor in casual vacancy due to Non-availability of previously appointed Secretarial Auditor.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Publication Of Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025",
      "datetime": "15-Nov-2025",
      "details": "Intimation of publication of unaudited standalone financial results of the company for the quarter and half year ended september 302025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kimia Bioscien. Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-05 10:11:01

Kimia Bioscien., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges in its operational and market performance.

Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend

2025-12-02 12:42:30

Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year.

Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend

2025-12-01 11:12:33

Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.

Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend

2025-12-01 11:12:33

Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.

Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend

2025-11-28 15:07:24

Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices.

Why is Kimia Bioscien. falling/rising?

2025-11-22 00:31:22

Stock Performance Against Benchmarks

Kimia Biosciences has underperformed markedly compared to the broader market indices over multiple time horizons. Over the past week, the stock declined by 7.59%, while the Sensex gained 0.79%. This negative trend extends over longer periods, with the stock falling 8.83% in the last month and a steep 30.59% over the past year, contrasting sharply with the Sensex’s 10.47% gain during the same period. Even over three and five years, the stock has lagged significantly, registering losses of 19.88% and 26.81% respectively, while the Sensex surged by 39.39% and 94.23%. These figures underscore persistent underperformance and investor caution surrounding the company.

Intraday Volatility and Trading Patterns

On 21-N...

Kimia Biosciences Q2 FY26: Margin Compression Overshadows Revenue Growth

2025-11-18 16:37:16

Kimia Biosciences Ltd., a Gurgaon-based pharmaceutical company specialising in bulk drug manufacturing, reported net profit of ₹1.02 crores for Q2 FY26, marking a sequential increase of 70.00% from ₹0.60 crores in Q1 FY26. However, year-on-year comparison reveals a concerning decline of 36.65% from ₹1.61 crores in Q2 FY25. The company's stock, trading at ₹34.00 with a modest market capitalisation of ₹159 crores, has struggled significantly, declining 27.66% over the past year whilst the broader Sensex gained 9.48%.

Kimia Biosciences Financial Trend Shifts to Flat Amid Mixed Quarterly Performance

2025-11-18 16:00:29

Kimia Biosciences, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable adjustment in its financial trend parameter, moving from a negative to a flat evaluation in the quarter ending September 2025. This shift reflects a stabilisation in key financial metrics despite ongoing challenges in profitability and margin performance.

Is Kimia Bioscien. overvalued or undervalued?

2025-11-18 08:18:31

As of 17 November 2025, the valuation grade for Kimia Bioscien. has moved from fair to attractive, indicating a positive shift in its market perception. The company is currently considered undervalued, especially when compared to its peers in the pharmaceuticals and biotechnology sector. Key ratios include a PE Ratio of 19.11, an EV to EBITDA of 10.35, and an impressive ROE of 82.13%. In comparison to its peers, Kimia Bioscien. stands out with a significantly lower PEG Ratio of 0.11, while Sun Pharma. is deemed expensive with a PE Ratio of 36.69 and an EV to EBITDA of 24.22. Other peers like Divi's Lab and Torrent Pharma are also classified as very expensive, with PE Ratios of 69.78 and 59.48, respectively. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -27.62% compared to the Sensex's 8.72%, the valuation metrics suggest that Kimia Bioscien. presents a compellin...

View All News

Announcement

Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

02-Dec-2025 | Source : BSE

Outcome of Board meeting under Regulation 30 of SEBI(Listing Obligations and disclosures Requirements) regulations 2015.

Intimation Regarding Proposed Appointment Of Secretarial Auditor In Casual Vacancy Due To Non-Availability Of Previously Appointed Secretarial Auditor.

28-Nov-2025 | Source : BSE

Intimation regarding proposed appointment of secretarial auditor in casual vacancy due to Non-availability of previously appointed Secretarial Auditor.